A novel biomarker to predict DNA-Repair-inhibitor response in stage I-III high risk breast cancer patients. (November 2022) - Barcaru, A.; Kuilman, M.M.; Wolf, D.; Yau, C.; Choy, E.B.M.; Audeh, W.M.; Brown-Swigart, L.; Hirst, G.L.; Symmans, F.W.; Liu, M.C.; Nanda, R.; Esserman, L.J.; et al.